"MEDEZE" Hosted Analyst Meeting to Showcase Business Potential Ahead of IPO Offering of 268 Million Shares | MEDEZE Investor Relation (MEDEZE)

03.09.2024

"MEDEZE" Hosted Analyst Meeting to Showcase Business Potential Ahead of IPO Offering of 268 Million Shares

"MEDEZE" Hosted Analyst Meeting to Showcase Business Potential Ahead of IPO Offering of 268 Million Shares

Dr. Veerapol Khemarangsan (top row, 7^th from right), Chief Executive Officer; Ms. Supakarn Kitchakosol (top row, 5^th from left), Chief Accounting and Financial Officer; Mr. Pipat Pisanuwongruk (top row, 6^th from right), Chief Accounting and Financial Officer of MEDEZE Treasury PTE. LTD.; Ms. Danita Pitaknetikul (top row, 5^th from right), Chief Business Development Officer; Mr. Piyawat Rajaphonsit (top row, 4^th from left), Chairman of the Investment Committee; and Assoc. Prof. Dr. Paiboon Sereewiwattana (top row, 2^nd from left), Financial Planning Advisor for MEDEZE Group Public Company Limited, participated in the MEDEZE Analyst Meeting.

MEDEZE is a leading service provider specializing in the analysis, isolation, cultivation, and storage of stem cells and the evaluation of immune cell potential (NK Cells). With over 13 years of experience, the company offers long-term stem cell storage solutions supported by cutting-edge innovations and technology.

Also present at the event was Mr. Payuphat Mahaphon (top row, 3^rd from left), Managing Director of Investment Banking at Yuanta Securities (Thailand) Co., Ltd., acting as the financial advisor. The meeting provided detailed information about the company's Initial Public Offering (IPO) of 268 million shares with a par value of 0.50 baht per share, representing up to 25.09% of the total issued and paid-up shares post-IPO.

During the event, MEDEZE presented an overview of its business operations and future plans in preparation for listing on the Stock Exchange of Thailand (SET) under the Services (SERVICE) / Health (HEALTH) sector. The meeting, attended by analysts from leading securities firms, was held at the Park Hyatt Bangkok.

IR Press Releases

Thai FDA Supports the Advanced Medical Industry by Hosting FDA EXPO 2026, Driving Thailand’s ATMPs onto the Global Stage; MEDEZE Showcases Its Comprehensive ATMP Sandbox Capabilities

MEDEZE Welcomes the Dental Innovation Foundation for Knowledge Exchange on Medical Innovation

MEDEZE Welcomes World NexGen 2026, Strengthening an International Network of Next-Generation Leaders in the Health Economy

MEDEZE Participates in Thailand ATMP Roadmap 2025, Reinforcing Its Role in Advancing Thailand’s Advanced Medical Industry

MEDEZE Wins Frost & Sullivan 2025 Award, Reinforcing Its Leadership in Stem Cell and Advanced Medical Innovation in Southeast Asia

MEDEZE Partners with Identity Dermatology Center, Signs MOU to Advance Regenerative Beauty Innovation and Position Thailand as a Medical & Wellness Tourism Hub

MEDEZE Targets 25% Growth in 2026, Accelerates Full-Scale Expansion into the Health Economy Partners with GPO to Establish a Joint Venture for Cell Culture Media Production, Upgrading from Biobank to Biopharma, While Advancing the JUMP+ Program to Strengthen Healthcare Capabilities and Sustainable Growth

“MEDEZE” Ready to Move Forward in Line with Government Policy, Driving Advanced Medical Products Across All Dimensions

MEDEZE Shares Knowledge, Welcomes NIDA Faculty and Students for Corporate Visit

MEDEZE Provides Medicines and Medical Supplies to Support Hat Yai Residents Amid Flood Crisis

MEDEZE Shares Vision on “Thailand Next Growth Engines” at FOLLOW THE FUTURE 2025

“MEDEZE” ร่วมส่งต่อความช่วยเหลือผู้ประสบอุทกภัยภาคใต้ สนับสนุนสิ่งของจำเป็นเพื่อบรรเทาความเดือดร้อนเร่งด่วน

MEDEZE Congratulates S Spine & Joint on Its Grand Opening Strengthening Its Role as a Next-Generation Health Organization Elevating Quality of Life for Thai People

MEDEZE Demonstrates Strong Q3/2025 Performance with THB 160 Million Net Profit Advances Toward Becoming “Thailand’s First ATMPs” and Strengthens Its Position as a Regional Medical Leader

MEDEZE Achieves Nearly THB 160 Million Net Profit in 9M/2025 “ATMPs Sandbox” Marks a Milestone in Advancing Hope for Disease Treatment

“MEDEZE” Advances Stem Cell Knowledge — Participates as Speaker at the 40th Annual Scientific Meeting of the Royal Thai College of Obstetricians and Gynaecologists

“MEDEZE” Shares Insights on “Stem Cell Innovation” at Yuanta Seminar Transforming Healthcare into the Investment Frontier of the Future

MEDEZE Participates in “Future Ready Beyond 2025” Seminar Highlighting Health and Technology Trends on a National Investment Stage

MEDEZE เข้าตามหลักเกณฑ์รับรองมาตรฐาน “ธนาคารเซลล์" ขานรับประกาศ “ราชกิจจาฯ” เดินหน้าสู่ผู้นำธุรกิจสุขภาพแห่งอนาคต

MEDEZE Participates in “The 3rd National Forum on Continuing Medical Education” Reaffirming Its Leadership in Next-Generation Medical Innovation

MEDEZE Welcomes KH Academy Enhancing Knowledge and Fostering Innovation in Future Medical Science

“MEDEZE” คว้ารางวัล “ธุรกิจด้านสุขภาพยอดเยี่ยมแห่งปี” ตอกย้ำผู้นำด้านนวัตกรรมสุขภาพสู่เป้าหมาย “HEALTH Economy” แห่งอนาคต

“MEDEZE” Joins as a Guest Speaker at “Bumrungrad Care for Children 2025” Reaffirming Its Role as a Regional Leader in Health Innovation

“MEDEZE” Welcomes Students from the Thammasat–Suksasongkroh School Science Program (WMW–TU–Skr) Inspiring the Next Generation Toward Advanced Medical Science

“MEDEZE Reinforces Its Leadership in Stem Cell Innovation Across Southeast Asia — Welcomes Indonesian Investors on an Exclusive Visit”

MEDEZE Welcomes Bumrungrad Executives, Showcasing World-Class Laboratory Capabilities to Drive Healthcare Innovation in Southeast Asia

MEDEZE advances its social responsibility mission by participating in a charity golf tournament to raise funds for the construction of the Outpatient Building at Phutthamonthon Hospital.

MEDEZE Reinforces Its Role as a Leader in Advanced Medical Business by Joining the Panel Discussion: ‘Preparing for the Great Crisis: Decoding the World’s Game

MEDEZE Joins the ‘Market’s New Magnet’ Forum to Share Its Vision as a Leader in the New Global Business Era, Reinforcing Its Commitment to Driving Future Health Innovations.

MEDEZE Achieves a Score of 86 in the 2025 AGM Checklist, Reinforcing Its Corporate Governance Standards.

MEDEZE Showcases First-Half 2025 Performance and Advances the ‘Sandbox’ Initiative to Develop Next-Generation Therapeutic Products.”

MEDEZE ทำกำไรครึ่งปี 68 ที่ 129 ลบ. รายได้รวม 408 ลบ. เดินหน้า “Sandbox” ต่อยอดผลิตภัณฑ์ยาเพื่อการบำบัดรักษาขั้นสูง

MEDEZE Participates in the 7th SMART Conference, Elevating Thai Aesthetic Medicine to Global Standards

“MEDEZE” ฉลอง 15 ปีสุดยิ่งใหญ่ “Future of Thailand HEALTH Economy” รวมพลังขับเคลื่อนเศรษฐกิจไทยด้วยการแพทย์แห่งอนาคต

MEDEZE ฉลอง 15 ปี อย่างยิ่งใหญ่ เดินหน้า “Sandbox” รวมพลังการแพทย์ไทยขับเคลื่อนเศรษฐกิจสู่ “HEALTH Economy”

"MEDEZE” ร่วมสานต่อพลังแห่งการให้ มอบสิ่งของจำเป็นแก่สถานสงเคราะห์เด็กอ่อนรังสิต

"MEDEZE” ต้อนรับนักวิเคราะห์และนักลงทุนจาก CGSI และ KKPFG ร่วมเจาะลึกอนาคตการแพทย์ระดับโลก

"MEDEZE โชว์ศักยภาพแพทย์ไทย ร่วมประชุมวิชาการ AAHRS 2025 ตอกย้ำผู้นำด้านการฟื้นฟูเส้นผมระดับภูมิภาค

“MEDEZE” Welcomes Dr. Khao, Researcher from the National Center for Genetic Engineering and Biotechnology (BIOTEC)

“MEDEZE” Extends Congratulations at the Grand Opening of “KLS Kasemrad Liposuction and Slimming Center BY La Ferly”

“MEDEZE” Welcomes General Lertrat, Who Banks Adipose-Derived Stem Cells as Part of His Long-Term Health Strategy

“MEDEZE” Reinforces Its Role as Thailand’s Leading Stem Cell Bank, Reports Soaring Profit in Q1/2025

“MEDEZE” Upholds Buddhist Traditions by Organizing the Annual Principal Buddha Casting Ceremony 2025 at Wat Kalyani Songtham

“MEDEZE” Advances Preparations to Renovate the Premises and Visits the ATMPs Sandbox Project at the Bangrak Medical Center Building

TIME Magazine Features MEDEZE GROUP and Showcases the Vision of Dr.Veerapol as a Regional Representative in the New Era of Sustainable Medicine

“MEDEZE” Hosts “Biolongevity: Technology for Longevity” in the Lao People's Democratic Republic, Aiming to Become a Regional Biotech Leader in CLMVT

MEDEZE Participates in ISO 20387:2018 Training to Elevate Biobanking Standards

"One Stem Cell Equals Medicine" — Ministry of Public Health, Vachira Phuket Hospital, and MEDEZE Group Join Forces to Advance the ATMPs Sandbox, Paving the Way for the Future of Advanced Thai Medicine

A Closer Look: Danita Phitaknetikul and Her Daughter Visit for Hair Root Touch-Up

MEDEZE Advances Its Vision with Launch of Pilot ESG Initiative, Aiming to Become a Sustainable Healthcare Organization of the Future

“MEDEZE” Welcomes CEO of BHI Clinic for a Visit to Asia’s First Hair Follicle Cell Cryopreservation Technology

MEDEZE Enhances Executive Leadership with the Appointment of Mr. Piyawat Rachpolsit as Vice Chairman, Aiming to Drive Strategic Growth in the Global Healthcare Sector

"MEDEZE Announces 1Q2025 Performance Results, Continues to Execute Ongoing Growth Strategy"

MEDEZE shows the first curve of profit in 2025, growing 27%, revenue growing by 20%. High demand for stem cell storage supports every business to expand.

Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited

"MEDEZE had the pleasure of welcoming clients from IFCG and provided them with detailed information on NK Cells, aiming to enhance in-depth medical knowledge."

MEDEZE จัดประชุมสามัญผู้ถือหุ้นประจำปี 2568 ผ่านสื่ออิเล็กทรอนิกส์ E-AGM ผถห.อนุมัติไฟเขียวทุกวาระ ตอกย้ำผลประกอบการโตอย่างต่อเนื่อง

MEDEZE Welcomes Executives from ‘Khongkwan Clinic’ to Explore Opportunities for Advancing Healthcare Business through Medical Innovation

“MEDEZE” เติมเต็มความสุขสุดเอ็กซ์คลูซีฟ ชวนลูกค้าคนพิเศษร่วมชม “Snowwhite”

MEDEZE Welcomes ABRM Executive Delegation for Discussions on Advancing Collaboration in Medical Innovation

“เมดีซ กรุ๊ป” ส่งต่อความรัก ร่วมแบ่งปันโอกาสสู่เด็กบ้านทานตะวัน

“MEDEZE” Brings Smiles to Phaya Thai Babies Home

“MEDEZE” Hosts an Official Visit for the Nursing Team from Rama 9 Hospital to Explore Its Operations

“MEDEZE” Spreads Joy to Children at Baan Srinakarin, Foundation for Slum Child Care

"MEDEZE" showcases its business potential at Opp Day Year End 2024.

"MEDEZE" celebrates the 2nd anniversary of "The Fountain of Youth."

"MEDEZE" explores the Health Care business in-depth at the Mitihoon Seminar.

MEDEZE Targets Record-High Revenue of Over 1 Billion THB in 2025 Invests 552 MB Acquiring Land for New Cell Bank to Support Expansion

"MEDEZE" presents its business outlook at the Analyst Meeting Year-End 2024.

"MEDEZE" delivered a special presentation at the grand opening of "VANA Longevity Clinic (Bangsaen)."

"MEDEZE" Signs MOU to Launch a Stem Cell Bank in the Philippines

“MEDEZE” and “IFGC” hosted Unlock the Miracle Inside You to reveal the secrets of stem cells, boosting immunity, and protecting against harmful diseases.

"Mediz Group" welcomes the CEO of Bitkub and Frost & Sullivan Executives.

MEDEZE Unveils “Hair Renaissance” Asia’s First Hair Follicle Cryopreservation Bank

"MEDEZE discusses opportunities to open a stem cell bank and visits the Ministry of Health, Manila, Republic of the Philippines."

"MEDEZE" welcomes CSI Investment Institute for a company visit.

MEDEZE x IFCG signing MOU to expand consultants network targeting high purchasing power customers.

MEDEZE Partners with IFCG, Signing MOU to Expand Sales Network Targeting High-Purchasing Power Clients

“MEDEZE” welcomes the Government Pharmaceutical Organization with an open house.

"MEDEZE" Explores Business Opportunities in Oman for Future Growth

"MEDEZE" Showcased Vision at "Follow The Future 2024 – UNRAVEL THE NEW ERA: Decoding the New World"

MEDEZE Signs Agreement with SHIBUYA for Automatic Cell Cultivation System A Smart Solution to Enhance the New Cell Bank Capabilities, Delivery Expected by June 2026

MEDEZE Wins the 'ACES Award' Recognized for Setting Outstanding Standards in Stem Cell Storage and Care

"MEDEZE" Participated in the 46th Annual Royal College of Orthopaedic Surgeons of Thailand Meeting

MEDEZE Opens on First Trading Day at 13.30 THB, Up 47.78% from IPO Price Pushes Forward with Business Expansion, Reinforcing Industry Leadership

"MEDEZE" Debuts on First Trading Day at 13.30 Baht, 47.78% Above IPO Price

"MEDEZE" Roadshow Provided In-Depth Business Insights on Yuanta Corporate Day

"MEDEZE" Presented to VI Investors, Showcasing Its Potential as a Leader in Stem Cells and Biotech in Thailand

"MEDEZE" Roadshow at the Stock Exchange Showcased Strong Fundamentals, Boosting Investors’ Confidence

MEDEZE Appoints Yuanta Securities as Underwriter Sets IPO Price at 9 Baht per Share, Subscription Period from October 2 – 4, 2024

"MEDEZE" Southern Roadshow in Songkhla Showcasing Strong Business Highlights

"MEDEZE" Expanded to the Northeast to Showcase Business Potential and Present to Investors in Udon Thani

"MEDEZE" Presented to Investors in Chiang Mai, Prepares for IPO Offering to List on SET

"MEDEZE" Presented to Investors in Preparation for IPO Offering to List on SET

ก.ล.ต. นับหนึ่งไฟลิ่ง “เมดีซ กรุ๊ป” ขาย IPO 268 ล้านหุ้น ขยายธุรกิจเซลล์รากผม ระบบจัดเก็บเซลล์ด้วยหุ่นยนต์

"MEDEZE" Hosted Analyst Meeting to Showcase Business Potential Ahead of IPO Offering of 268 Million Shares

The SEC and the SET Visited "MEDEZE" Operations

MEDEZE Welcomed the Ambassador of Oman to the Kingdom of Thailand